2 months ago
MNMD
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 5%
#215 out of 4565 analysts
Average Return
+12.32%
Win Rate
47%80 out of 170
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Buy |
Mind Medicine IncMNMD | +223.95% | $2.63 | $8.52 | 2023-10-23 - 2024-04-25 | Buy |
Mind Medicine IncMNMD | +222.26% | $3.01 | $9.70 | 2023-03-10 - 2024-03-08 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Marinus Pharmaceuticals IncMRNS | 7 | Hold | $3.00 | +111.27% | Downgrades | 11 days ago |
Applied Therapeutics IncAPLT | 2 | Buy | $12.00 | +183.69% | Reiterates | 16 days ago |
Regeneron Pharmaceuticals IncREGN | 18 | Buy | $1,189.00 | +33.49% | Reiterates | 18 days ago |
Intra Cellular Therapies IncITCI | 13 | Buy | $86.00 | +19.23% | Reiterates | 24 days ago |
Neumora Therapeutics IncNMRA | 3 | Buy | $31.00 | +242.16% | Reiterates | a month ago |
Incyte CorpINCY | 12 | Hold | $65.00 | +27.00% | Reiterates | a month ago |
Hookipa Pharma IncHOOK | 7 | Buy | $5.00 | +520.35% | Reiterates | a month ago |
Sage Therapeutics IncSAGE | 16 | Hold | $26.00 | +91.46% | Reiterates | 2 months ago |
Ptc Therapeutics IncPTCT | 12 | Hold | $28.00 | +9.85% | Reiterates | 2 months ago |
Igm Biosciences IncIGMS | 11 | Buy | $21.00 | +174.51% | Reiterates | 2 months ago |
Mind Medicine IncMNMD | 8 | Buy | $22.00 | +158.22% | Maintains | 2 months ago |
Pliant Therapeutics IncPLRX | 10 | Buy | $54.00 | +354.55% | Maintains | 2 months ago |
Biogen IncBIIB | 24 | Buy | $364.00 | +79.79% | Reiterates | 2 months ago |
Xenon Pharmaceuticals IncXENE | 11 | Buy | $55.00 | +37.16% | Maintains | 2 months ago |
89bio IncETNB | 12 | Hold | $14.00 | +69.70% | Maintains | 2 months ago |
Sarepta Therapeutics IncSRPT | 18 | Buy | $157.00 | +23.24% | Maintains | 2 months ago |
Prothena Corp Public Ltd CoPRTA | 7 | Hold | $35.00 | +70.23% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 17 | Hold | $75.00 | +14.91% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 40 | Hold | $420.00 | +5.61% | Maintains | 3 months ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | +14.29% | Maintains | 5 months ago |
Neurocrine Biosciences IncNBIX | 11 | Hold | $121.00 | -12.17% | Maintains | 6 months ago |
Karyopharm Therapeutics IncKPTI | 6 | Buy | $3.00 | +183.02% | Maintains | 6 months ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | -31.78% | Maintains | 6 months ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | +20.19% | Maintains | 7 months ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | 0.00% | Maintains | 7 months ago |
Biocryst Pharmaceuticals IncBCRX | 9 | Buy | $10.00 | +140.38% | Reiterates | 7 months ago |
Galapagos NvGLPG | 9 | Hold | $41.00 | +43.21% | Maintains | a year ago |
Atai Life Sciences NvATAI | 3 | Hold | $9.00 | N/A | Maintains | 2 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 2 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 4 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $690.00 | N/A | Initiates Coverage On | 5 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 6 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 7 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.